During the Scientific Sessions, Scott A. Summers, PhD, reviewed the strong association of serum ceramides with insulin resistance and major adverse cardiac events. He also discussed new therapeutic approaches to lower ceramides and combat diabetes and its comorbidities.
ICYMI: Presenter Perspectives: Ceramides—The New Cholesterol?
